eHealth Market Size, Share, and Trends 2024 to 2034

eHealth Market (By Product: ePrescribing, EHR, Telemedicine, mHealth, Clinical Decision Support, Others; By Service: Diagnostic, Monitoring, Healthcare Strengthening, Treatment, Database Management; By End Use: Healthcare Providers, Insurers, Healthcare Consumers, Government; By Deployment: On-premise, Cloud-based) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032

  • Last Updated : July 2023
  • Report Code : 1588
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on EHealth Market 

5.1. COVID-19 Landscape: EHealth Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global EHealth Market, By Product

8.1. EHealth Market, by Product Type, 2023-2032

8.1.1. ePrescribing

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. EHR

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Telemedicine

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. mHealth

8.1.4.1. Market Revenue and Forecast (2021-2032)

8.1.5. Health Management

8.1.5.1. Market Revenue and Forecast (2021-2032)

8.1.6. Clinical Decision Support

8.1.6.1. Market Revenue and Forecast (2021-2032)

8.1.7. Information System

8.1.7.1. Market Revenue and Forecast (2021-2032)

8.1.8. Radiology Information Systems

8.1.8.1. Market Revenue and Forecast (2021-2032)

8.1.9. Laboratory Information Systems

8.1.9.1. Market Revenue and Forecast (2021-2032)

8.1.10. Cardiovascular Information Systems

8.1.10.1. Market Revenue and Forecast (2021-2032)

8.1.11. Others

8.1.11.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global EHealth Market, By Service

9.1. EHealth Market, by Service, 2023-2032

9.1.1. Diagnostic

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Monitoring

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Healthcare Strengthening

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. Treatment

9.1.4.1. Market Revenue and Forecast (2021-2032)

9.1.5. Database Management

9.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global EHealth Market, By End Use Type 

10.1. EHealth Market, by End Use Type, 2023-2032

10.1.1. Healthcare Providers

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Insurers

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Healthcare Consumers

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Government

10.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global EHealth Market, By Deployment Type 

11.1. EHealth Market, by Deployment Type, 2023-2032

11.1.1. On-premise

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Cloud-based

11.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global EHealth Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2032)

12.1.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.1.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.1.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.1.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2032)

12.2.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.2.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.2.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.2.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.2.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.2.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2032)

12.3.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.3.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.3.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.3.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.3.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.3.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2032)

12.4.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.4.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.4.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.4.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.4.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.4.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.5.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)

12.5.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

Chapter 13. Company Profiles

13.1. Allscripts Healthcare Solutions, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Koninklijke Philips N.V.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthineers

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. International Business Machines Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. General Electric Company

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. InTouch Health

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Athenahealth, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Cisco Systems, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. UnitedHealth Group

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medtronic plc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client